Skip to main content
Premium Trial:

Request an Annual Quote

Vijay Aggarwal


Vijay Aggarwal has joined the board of directors of IBT Reference Laboratory, the international contract research and diagnostic testing lab said this week.

Aggarwal will provide IBT with strategic counsel in the areas of new business initiatives, operational protocol, and research and development. He currently serves as president and chief executive officer of Aureon Laboratories. Prior to joining Aureon, Aggarwal held positions at AAI Development Services, SmithKline Beecham Clinical Laboratories, and Quest Diagnostic Ventures.

He holds a PhD in pharmacology and toxicology from the Medical College of Virginia.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.